Healthcare provider profile · identity verified

Kyla-Gaye Pinnock, MD

Family Practice · NEW CASTLE, DE · NPI 1376106948

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	312	104
Amlodipine Besylate	Amlodipine Besylate	234	76
Metformin Hcl	Metformin Hcl	182	47
Rosuvastatin Calcium	Rosuvastatin Calcium	155	56
Losartan Potassium	Losartan Potassium	141	51
Levothyroxine Sodium	Levothyroxine Sodium	124	40
Lisinopril	Lisinopril	118	40
Hydrochlorothiazide	Hydrochlorothiazide	113	38
Fluticasone Propionate	Fluticasone Propionate	103	44
Omeprazole	Omeprazole	97	33
Albuterol Sulfate Hfa	Albuterol Sulfate	96	32
Metoprolol Succinate	Metoprolol Succinate	94	30
Simvastatin	Simvastatin	74	22
Gabapentin	Gabapentin	73	24
Montelukast Sodium	Montelukast Sodium	65	19
Glipizide Er	Glipizide	58	17
Metformin Hcl Er	Metformin Hcl	57	20
Valsartan	Valsartan	47	16
Pantoprazole Sodium	Pantoprazole Sodium	44	22
Alendronate Sodium	Alendronate Sodium	43	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	14
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Potassium Chloride	Potassium Chloride	35	13
Pravastatin Sodium	Pravastatin Sodium	35	13
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Ozempic	Semaglutide	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Furosemide	Furosemide	31	15
Trazodone Hcl	Trazodone Hcl	30	13
Tamsulosin Hcl	Tamsulosin Hcl	29	11
Famotidine	Famotidine	28	11
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Sertraline Hcl	Sertraline Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Jardiance	Empagliflozin	26	11
Azelastine Hcl	Azelastine Hcl	25	11
Synthroid	Levothyroxine Sodium	25	suppressed
Trulicity	Dulaglutide	24	suppressed
Baclofen	Baclofen	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Prednisone	Prednisone	21	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Carvedilol	Carvedilol	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Naproxen	Naproxen	19	12
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	11
Eliquis	Apixaban	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Nystatin	Nystatin	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Atenolol	Atenolol	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Azithromycin	Azithromycin	13	12
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fluconazole	Fluconazole	13	11
Ibuprofen	Ibuprofen	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Glipizide	Glipizide	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error